Accepted for Publication: June 1, 2020.
Published Online: August 5, 2020. doi:10.1001/jamadermatol.2020.2800
Correction: This article was corrected on September 23, 2020, to fix an error in the byline.
Corresponding Author: Joanna Harp, MD, Department of Dermatology, NewYork-Presbyterian/Weill Cornell Medical College, 1305 York Ave, 9th Floor, New York, NY 10021 (email@example.com).
Author Contributions: Drs Droesch and Harp had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Droesch, Magro, Harp.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Droesch, Do, Lee, Harp.
Critical revision of the manuscript for important intellectual content: Droesch, DeSancho, Lee, Magro, Harp.
Statistical analysis: Harp.
Administrative, technical, or material support: Magro, Harp.
Supervision: Magro, Harp.
Conflict of Interest Disclosures: Dr DeSancho reported serving on the Advisory Boards for Bio Products Laboratory and Sanofi-Genzyme. No other disclosures were reported.
C , Català
A , Carretero Hernández
et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol
. Published online April 29, 2020. PubMedGoogle Scholar
M , Bottino
N , Tagliabue
et al. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost
. Published online April 17, 2020. PubMedGoogle Scholar
S , Huang
M , Li
D , Tang
N . Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. J Thromb Thrombolysis
. Published online April 3, 2020. PubMedGoogle Scholar